Aims and Scope of Pharmaceutical Development and Technology
Pharmaceutical Development and Technology is a peer reviewed medical journal that is published by Taylor & Francis. It covers research on the design, development, manufacture, and evaluation of drug delivery systems. The editor-in-chief is Raid Alany of (Kingston University), who succeeded Michael A. Akers (Baxter BioPharma Solutions, Bloomington, Indiana, United States). Less
Key Metrics
CiteScore 

5.4
H-Index 

66
Impact Factor 

< 5
SJR 

Q2Pharmaceutical Science

SNIP 

0.75
Recommended pre-submission checks
Powered by 

Topics Covered on Pharmaceutical Development and Technology
Pharmaceutical Development and Technology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1996 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmaceutical Development and Technology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pharmaceutical Development and Technology
Berberrubine solid dispersions prepared by hot-melt extrusion technology: characterization, enhanced solubility,composition-dependent release, and improved bioavailability in rats
- 20 Apr 2026
- Pharmaceutical Development and Technology
Spray-Dried Zinc-Alginate Microparticles for Antibiotic Removal from Water: A Promising Approach to Mitigate Antibiotic Resistance
- 16 Apr 2026
- Pharmaceutical Development and Technology
Advanced skin delivery of L-arginine: design, characterization, and anti-aging efficacy of optimized cubosomal nanocarriers
- 7 Apr 2026
- Pharmaceutical Development and Technology
The use of design of experiments and green chemistry for the preparation of a taste-masked metronidazole-loaded cubosomal nanostructured oral gel
- 6 Apr 2026
- Pharmaceutical Development and Technology
Tumor cell membrane-camouflaged nanoparticles co-delivering docetaxel and metformin for enhanced synergistic therapy of HER2-positive breast cancer
- 4 Apr 2026
- Pharmaceutical Development and Technology
Application of a phosphorylcholine-based copolymer, poly(MPC-co-BMA) on vial stoppers using a cold plasma deposition process
- 29 Mar 2026
- Pharmaceutical Development and Technology
Berberrubine solid dispersions prepared by hot-melt extrusion technology: characterization, enhanced solubility,composition-dependent release, and improved bioavailability in rats
- 20 Apr 2026
- Pharmaceutical Development and Technology
Spray-Dried Zinc-Alginate Microparticles for Antibiotic Removal from Water: A Promising Approach to Mitigate Antibiotic Resistance
- 16 Apr 2026
- Pharmaceutical Development and Technology
Advanced skin delivery of L-arginine: design, characterization, and anti-aging efficacy of optimized cubosomal nanocarriers
- 7 Apr 2026
- Pharmaceutical Development and Technology
The use of design of experiments and green chemistry for the preparation of a taste-masked metronidazole-loaded cubosomal nanostructured oral gel
- 6 Apr 2026
- Pharmaceutical Development and Technology
Tumor cell membrane-camouflaged nanoparticles co-delivering docetaxel and metformin for enhanced synergistic therapy of HER2-positive breast cancer
- 4 Apr 2026
- Pharmaceutical Development and Technology
Application of a phosphorylcholine-based copolymer, poly(MPC-co-BMA) on vial stoppers using a cold plasma deposition process
- 29 Mar 2026
- Pharmaceutical Development and Technology